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Abstract
Backround: Sigmoid colon cancer metachronous metastases commonly occur in the liver and lungs with sporadic
reports also to the spleen, stomach, thyroid gland, abdominal wall and upper urinary tract. This is a rare case of
metachronous metastases invading the mesorectum and the abdominal wall.
Case presentation: A 72-year-old female underwent sigmoidectomy for stage I (T2N0 M0) sigmoid colon cancer
in May 2008. In June 2009, an abdominal computed tomography scan revealed a tumor 2 cm in size at the lower
anterior mesorectum and a second mass 2 cm in size at the anterior abdominal wall midline. Total colonoscopy
showed no mucosal lesion. The serum carcinoembryonic antigen level was normal. A biopsy of the mesorectum
tumor showed similar histologic characteristics with the primary tumor. Since no other site of recurrence was
identified, an abdominoperineal resection was attempted. During the operation and after the removal of the
incision recurrence, sinus bradycardia and signs of myocardial ischemia were noticed. A loop transverse colostomy
was immediately perfomed and the operation was terminated. Postoperative cardiologic examination revealed an
acute myocardium infract. Chemo-radiation of the mesorectum tumor and re-evaluation for surgical excision was
decided.
Conclusion: Metachronous metastasis of the mesorectum from sigmoid colon cancer is extremely rare. Although
patterns of lymphatic spread from rectal cancer to sigmoid colon have recently been demonstrated, there is no
evidence of metachronous mesorectum invasion from sigmoid colon cancer. This could be the issue for future
trials.
Background
Colon cancer as one of the most commonly diagnosed
cancers around the world has an improved prognosis
due to the development of diagnostic and therapeutic
procedures. Overall survival however, can be seriously
shortened, mostly in the presence of distant metastasis
during follow-up. Liver is the commonest site of meta-
chronous metastases in approximately one fourth of the
patients, followed by the lungs [1]. Sporadic reports also
demonstrate the spleen, thyroid gland, stomach, urinary
system and abdominal wall as sites of possible reccur-
ence [2-4]. This is a rare case of a sigmoid colon cancer
with metachronous metastases of the mesorectum and
the abdominal wall.
Case Presentation
A 72-year-old female was admitted to hospital suffering
from fatigue, weight loss and rectal bleeding. Total colono-
scopy demonstrated adenocarcinoma of the sigmoid colon
at 25 cm from the anal verge. A chest x-ray was normal.
No sites of distant metastasis were reported on abdominal
computed tomography (CT) scan. The serum carcinoem-
bryonic antigen level was normal. The patient underwent
sigmoidectomy in May 2008. During the operation, the
left ovary was fixed at the site of the sigmoid colon cancer
and was removed en block. Thorough macroscopic exami-
nation of the liver and rest of the abdomen showed no
sign of metastatic disease. Histopathological examination
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mucus-producing adenocarcinoma, 3 cm in diameter
located 5 cm from the peripheral surgical margin (figure
1). The tumor invaded into but not beyond the muscularis
propria (T2). Ki 67 antigen and p53 tumor suppressor pro-
tein staining were positive and epidermal growth factor
receptor (EGFR) negative. The left ovary was free of neo-
plasmatic tissue. Only four lymph nodes were counted,
free of metastatic adenocarcinoma. The patient had an
uneventful recovery. On rectum examination one year
later a palpable extramucosal mass was noticed at the
anterior rectum wall. An abdominal CT scan revealed a
tumor 2 cm in size at the lower anterior mesorectum in
close relation with the posterior vaginal wall and a second
mass 2 cm in size at the anterior abdominal wall midline
(figure 2, 3). Total colonoscopy showed no mucosal lesion.
A chest x-ray was normal. Rectal endoscopic ultrasound
(EUS) showed a tumor infiltrating the rectum muscularis
propria from outside. Core needle biopsy demonstrated
the presence of a mucus producing adenocarcinoma with
the same histological futures with the primary tumor and
therefore it was considered as metachronous metastasis.
Serum carcinoembryonic antigen level was normal. Since
no other site of recurrence was identified, an abdomino-
perineal resection was attempted [5]. At laparotomy, the
anterior abdominal wall mass was located at the site of
previous incision and after complete resection, fast biopsy
showed adenocarcinoma. Surgical examination of the
abdominal cavity showed no sign of reccurence. At that
time, sinus bradycardia and ST segment depression was
noticed on electrocardiogram (ECG) monitoring. The ter-
mination of the operation was decided and a loop trans-
verse colostomy was immediately perfomed. Postoperative
cardiologic examination revealed an acute muocardium
infract and the patient was treated respectively. Chemo-
radiation of the mesorectum tumor and re-evaluation for
surgical excision was decided and she was discharged on
the eleventh post operative day.
Figure 1 Moderately differentiated adenocarcinoma (HE × 200). The glands are lined by neoplastic cells with hyperchromatic nuclei. The
tumor was accompanied with small mucinous lakes lind by well-differentiated epithelial cells. The tumor invades all intestinal wall.
Figure 2 A pelvic CT showed a tumor 2 cm in size at the lower anterior mesorectum.
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Recurrence after curative resection of colon adenocarci-
noma is a major determinant of survival and it seems to
increase as the primary tumor stage advance. In this
case, a sigmoid adenocarcinoma is infiltrating 2/3 of
muscularis propria with four lymph nodes harvested
free of metastatic disease. According to TNM classifica-
tion this is a stage I (TIN0 M0) colon cancer but with
inadequate lymph node evaluation [6-8]. Even though
the literature lacks consensus as to what the exact num-
ber of lymph nodes by stage should be, a minimal num-
ber of twelve lymph nodes is recommended [9-13].
Nevertheless, metachronous metastasis to the mesorec-
tum of a moderately differentiated T2 sigmoid adeno-
carcinoma with adequate peripheral surgical margin is
extremely rare. The pathway tumor cells followed is
unknown but one could suspect lymphatic spread. This
is justified by the inadequate lymph node excision. But
even if this is true, downward lymphatic flow is not
common [14,15]. Recently, lymphatic spread from rectal
cancer to the sigmoid colon lymph nodes was demon-
strated in as much as 20% [16]. It seems that lymph
flow is not only towards the paraortic lymph nodes but
follows a more diffuse pattern. In addition, it is known
that wound recurrence incidence is less than 1% and is
probably a result of implanted cancer cells on the surgi-
cal wound during removal of the surgical specimen [17].
This case is important in showing that metachronous
metastasis of the mesorectum from sigmoid colon can-
cer is possible, probably due to downward lymphatic
cancer spread. Perhaps, there is a need of a more
thorough investigation of the mesorectum region in sig-
moid colon cancer during preoperative imaging. There
is no similar report published in the literature.
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